-
Sodium benzoate
- CAS:532-32-1
- MW:144.10317
- MF:C7H5NaO2
Sodium benzoate, with the chemical formula C7H5NaO2, has the CAS number 532-32-1. It appears as a white crystalline powder with no distinct odor. The basic structure of sodium benzoate consists of a benzene ring attached to a carboxyl group and a sodium ion. This compound is highly soluble in water. Sodium benzoate is generally recognized as safe for consumption and is commonly used as a food preservative. However, it may cause allergic reactions in some individuals. In addition, prolonged or excessive exposure to sodium benzoate may have adverse effects on the liver and kidneys. It is important to handle this chemical with care and follow proper safety precautions.
Applicable Fields
Food Preservation: Sodium benzoate is widely used as a preservative in various food and beverage products. Its purpose in this field involves its ability to inhibit the growth of bacteria, yeasts, and molds, thereby extending the shelf life of perishable goods. The mechanism of action in food preservation is based on the ability of sodium benzoate to disrupt the metabolic processes of microorganisms, preventing their growth and proliferation.
Pharmaceuticals: Sodium benzoate is also utilized in the pharmaceutical industry. It is commonly used as a preservative in liquid medications, such as syrups and suspensions, to prevent microbial contamination. The mechanism of action in pharmaceutical applications is similar to that in food preservation, where sodium benzoate inhibits the growth of microorganisms and ensures the safety and stability of the medication.
Storage
Conditions: Store in a cool and dry place.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | 2gm/kg (2000mg/kg) | FAO Nutrition Meetings Report Series. Vol. 53A, Pg. 34, 1974. | |
frog | LDLo | subcutaneous | 100mg/kg (100mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1313, 1935. | |
guinea pig | LDLo | intraperitoneal | 1400mg/kg (1400mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1313, 1935. | |
guinea pig | LDLo | subcutaneous | 1gm/kg (1000mg/kg) | Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 28(1), Pg. 45, 1963. | |
mouse | LD50 | intramuscular | 2306mg/kg (2306mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 307, 1956. | |
mouse | LD50 | intravenous | 1440mg/kg (1440mg/kg) | Medicinal Chemistry, A Series of Reviews. Vol. 6, Pg. 290, 1963. | |
mouse | LD50 | oral | 1600mg/kg (1600mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 51(1), Pg. 75, 1986. |
rabbit | LD50 | oral | 2gm/kg (2000mg/kg) | ? | FAO Nutrition Meetings Report Series. Vol. 53A, Pg. 34, 1974. |
rabbit | LD50 | subcutaneous | 2gm/kg (2000mg/kg) | FAO Nutrition Meetings Report Series. Vol. 53A, Pg. 34, 1974. | |
rat | LD50 | intravenous | 1714mg/kg (1714mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 253, 1942. |
rat | LD50 | oral | 4070mg/kg (4070mg/kg) | Journal of Industrial Hygiene and Toxicology. Vol. 30, Pg. 63, 1948. | |
rat | LD50 | subcutaneous | 2gm/kg (2000mg/kg) | Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 28(1), Pg. 45, 1963. |
precursor: |
product: |